Document 0169
 DOCN  M9590169
 TI    Individualisation of HIV therapy: the clinician's perspective.
 DT    9509
 AU    Gazzard BG; Moyle GJ; Chelsea and Westminster Hospital, London.
 SO    Br J Clin Pract. 1995 May-Jun;49(3):145-7. Unique Identifier : AIDSLINE
       MED/95298616
 AB    Assessment of clinical and laboratory markers of HIV infection may be
       used to individualise antiretroviral therapy. Data suggest that measures
       of viral load may be of considerable value as both a baseline and
       dynamic therapy marker, making these tools particularly useful in
       driving therapeutic decisions. Similarly, in-vitro data regarding
       intracellular pharmacokinetics and activity, resistance patterns and
       potential synergy of antiretroviral agents may be used to guide
       selection of optimal treatment regimens in clinical practice.
 DE    Antiviral Agents/THERAPEUTIC USE  Decision Making  Human  HIV
       Infections/*THERAPY  Physician's Practice Patterns  JOURNAL ARTICLE
       REVIEW  REVIEW, TUTORIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).